Nektar Therapeutics recently presented Phase 2b data for its T-reg–enhancing biologic rezpegaldesleukin in atopic dermatitis and alopecia areata at the 2026 American Academy of Dermatology meeting, ...

Congo will receive some migrants as part of a new deal under the Trump administration’s third-country program, its government ...